Drugs / Royalactina
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07509268 Comparator | Sep 2022 → Sep 2025 | ulcer of lower limbs | Autonomous University of Nuevo León | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Royalactina | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07509268 ↗ |